| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.079 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |